Aurora Cannabis (TSE:ACB) Trading 20.8% Higher – Still a Buy?

Aurora Cannabis Inc. (TSE:ACBGet Free Report) shares shot up 20.8% during trading on Tuesday . The stock traded as high as C$4.91 and last traded at C$4.87. 1,683,109 shares were traded during trading, an increase of 311% from the average daily volume of 409,698 shares. The stock had previously closed at C$4.03.

Analysts Set New Price Targets

ACB has been the topic of several analyst reports. TD lowered their target price on Aurora Cannabis from C$10.00 to C$8.00 and set a “buy” rating on the stock in a research note on Friday, June 12th. Canaccord Genuity Group decreased their price target on Aurora Cannabis from C$6.50 to C$5.00 and set a “buy” rating for the company in a report on Tuesday, June 30th. Finally, BMO Capital Markets upgraded shares of Aurora Cannabis to a “hold” rating in a research report on Wednesday, August 5th. Three equities research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of C$7.17.

Get Our Latest Report on ACB

Aurora Cannabis Trading Up 20.8%

The firm has a market capitalization of C$301.66 million, a price-to-earnings ratio of -2.51 and a beta of 0.25. The business’s 50 day moving average price is C$4.06 and its 200-day moving average price is C$4.61. The company has a debt-to-equity ratio of 4.30, a current ratio of 5.36 and a quick ratio of 2.48.

Aurora Cannabis (TSE:ACBGet Free Report) last announced its quarterly earnings data on Wednesday, August 5th. The company reported C($0.07) EPS for the quarter. Aurora Cannabis had a negative net margin of 9.53% and a negative return on equity of 5.21%. The firm had revenue of C$67.55 million during the quarter. Equities analysts forecast that Aurora Cannabis Inc. will post -0.22 EPS for the current fiscal year.

About Aurora Cannabis

(Get Free Report)

Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael ’71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.

Further Reading

Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.